EAHAD/LinkedIn
Aug 3, 2026, 12:44
Replaying the CSL Symposium on Gene Therapy Durability in Haemophilia – EAHAD
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
“Missed the CSL symposium on ‘Durability of gene therapy in haemophilia? Bridging trial results with clinical practice’ at EAHAD 2026?
The full session is now available on the EAHAD Academy.
Replay the session.
Free access”
Stay updated with Hemostasis Today.
-
Aug 9, 2026, 02:26Exploring the Future of Rare Bleeding Disorder Treatment at EHC 2026
-
Aug 9, 2026, 02:08Shivam Bansal: Targeting Chemotherapy-Induced Thrombocytopenia in Children with Romiplostim
-
Aug 9, 2026, 01:48Paolo Zamboni: Treating Post-Thrombotic Syndrome by Eliminating Venous Reflux
-
Aug 8, 2026, 20:37Tammuella Chrisentery-Singleton: What Comes Next for Hemophilia Care With Non-Factor Therapies?
-
Aug 8, 2026, 20:36Michelle Cha: The Evolving Role of Nurse Coordinators in Hemophilia Gene Therapy
-
Aug 8, 2026, 20:35Benjamin Schumacher: The Future of Holistic Haemophilia A Care
-
Aug 8, 2026, 20:33Delilah F.: March Is Blood Clot Awareness Month
-
Aug 8, 2026, 20:31Jackie Maybin: Top 10 Research Priorities for Problematic Menstrual Bleeding in the UK
-
Aug 8, 2026, 17:02Mohammed Murad Hossain: Highlights from the 2nd Haematology and HSCT Workshop in Dhaka